IL22583A - Pilocarpine benzoate - Google Patents

Pilocarpine benzoate

Info

Publication number
IL22583A
IL22583A IL2258364A IL2258364A IL22583A IL 22583 A IL22583 A IL 22583A IL 2258364 A IL2258364 A IL 2258364A IL 2258364 A IL2258364 A IL 2258364A IL 22583 A IL22583 A IL 22583A
Authority
IL
Israel
Prior art keywords
pilocarpine
benzoate
preparation
reacted
organic solvent
Prior art date
Application number
IL2258364A
Original Assignee
Plantex Ltd
Pfeffer P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantex Ltd, Pfeffer P filed Critical Plantex Ltd
Priority to IL2258364A priority Critical patent/IL22583A/en
Publication of IL22583A publication Critical patent/IL22583A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Description

This invention consists in a hitherto unknown salt of pilocarpine, the alkaloid obtainable from, for example, the leaves of Pilocarpus Jaborandi or Pilocarpus microphallus. of pilocarpine with conventional acids, the hydrochloride and nitrate, are used for therapeutical purposes, especially for the treatment of glaucoma by external application. In this use they have the drawback that their pH in solution is relatively low and the eye liquid becomes undesirably acidic* The invention provides a new pilocarpine salt which does not have this drawback, namely: pilocarpine benzoate.
This new compound can be prepared by the direct reaction of pilocarpine with benzoic acid, or by the double decompositio of another pilocarpine salt with a benaoate.
The reaction is asa rule carried out in an aqueous or organic-solvent medium.
The new pilocarpine benaoate can be prepared in a pure crystalline form. The purest samples so ar prepared have the melting pint 93 - 95°C and a specific rotation (in a as een oun t at the desired therapeutic ophthalmologlcal properties of pilocarpine benzoate are at least equal to those of the conventional pilocarpine salts, apart from their considerable advantage of not appreciably lowering the pH of the eye liquid.
The invention is illustrated by the following Examples to which it ia not limited* Example 1 grams of pilocarpine base are admixed to the solution of 5.9 grams of benzoic acid in 25 ml of methanol, then the volume of the reaction is reduced to one thir^d by evaporation of the methanol. There forms a white crystalline mass of pilocarpine benzoate which is recrystallized from amyl alcohol. After recrystallization the pure product has the melting point and optical rotation stated above* Example 2 grams of pilocarpine base are taken up in 10 ml of amyl alcohol and admixed with a hot solution of 5.9 grams of benzoic acid i 40 ml of amyl alcohol· The mixture is left to cool and the crystalline mass of pilocarpine benzoate thereby formed is separated from the solvent by filtration. Hecrystabilization from amyl alcohol yields the same pure product as in Example 1.
Example 3 A concentrated aqueous solution of 10 grams of pilocarpine hydrochloride is admixed with the solution of 6.3 grams of sodium benzoate i 10 ml of water. The aqueous reaction solutio is extracted with chloroform whereby pilocarpine benzoate is transferred into the solvent phase while sodium chloride remains in the aqueous phase. The solvent phase is separated and dried over sodium sulfate, then the chloroform is completely evaporated. The dry residue of pilocarpine benzoate is recryatallized from butanol and is then as pure as the product of Examples 1 and 2·

Claims (1)

  1. HAVIHCa1 HOW particularly described and ascertained the nature of our said invention and in what manner the same is to be performed, we declare that what we claim is:-1, Pilocarpine benzoate. 2· Pilocarpine benzoate, being a crystalline product of m.p, 93 - 95°C and [dj ^« + 65° (in 25¾«-by-weight aqueous solution), 3. A process for the preparation of pilocarpine benzoate, wherein pilocarpine base is reacted with benzoic acid in an organic solvent medium. 4· A process for the preparation of pilocarpine benzoate, wherein another pilocarpine salt, e.g. the hydrochloride, a reacted with a benzoate, e.g. the sodium salt, in an aqueous medium, the reaction mixture is extracted with an organic solvent, and pilocarpine benzoate is recovered from the solvent extract. 5· Process for the preparation of pilocarpine benzoate substantially as described with reference to the Bxamples. 6. Pilocarpine benzoate, when prepared by the process according to Claim 3, 4 or 5· 7· Therapeutic, especially opthalmological, preparations containing pilocarpine benzoate. Dated this 7th day of December, 1964
IL2258364A 1964-12-08 1964-12-08 Pilocarpine benzoate IL22583A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL2258364A IL22583A (en) 1964-12-08 1964-12-08 Pilocarpine benzoate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL2258364A IL22583A (en) 1964-12-08 1964-12-08 Pilocarpine benzoate

Publications (1)

Publication Number Publication Date
IL22583A true IL22583A (en) 1968-03-28

Family

ID=11043443

Family Applications (1)

Application Number Title Priority Date Filing Date
IL2258364A IL22583A (en) 1964-12-08 1964-12-08 Pilocarpine benzoate

Country Status (1)

Country Link
IL (1) IL22583A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023143575A1 (en) * 2022-01-29 2023-08-03 南京济群医药科技股份有限公司 M-choline receptor agonist compound, preparation method therefor and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023143575A1 (en) * 2022-01-29 2023-08-03 南京济群医药科技股份有限公司 M-choline receptor agonist compound, preparation method therefor and use thereof

Similar Documents

Publication Publication Date Title
AT366050B (en) METHOD FOR PRODUCING A HYDRATED CRYSTALLINE FORM OF THE SODIUM SALT OF AN OXIDE DERIVATIVE OF THE 7-AMINOTHIAZOLYL ACETAMIDOCEPHALOSPO RANIC ACID
US3959247A (en) TRH tartrate crystals
DE2112026B2 (en) 3-Phenyl-H2- [pyrroUdinyl- (l)] äthylamino) -3,4dihydroisoquinoline, its preparation and the medicinal compositions containing it
US3707534A (en) Method for production of lactulose concentrate
IL22583A (en) Pilocarpine benzoate
US3532684A (en) Molecular compounds of inosine and tryptophan
US2727041A (en) Isonicotinyl hydrazone of m-formyl-benzene sulfonic acid
JPS6358839B2 (en)
Parke et al. The preparation and properties of sodium d-pantothenate
US1954389A (en) Process of manufacturing optically active mono-hydroxyphenyl methylamino-ethanols-1
US2950287A (en) Preparation of water soluble epinochrome derivatives
US3790587A (en) Antimycotic benzisothiazoline derivatives
US3290325A (en) Soluble alkanol ammonium thiazolidine carboxylates
Serajuddin Comparative thermal properties of the monohydrates of sodium theophylline and theophylline
US4124636A (en) Method of preparing monopotassium L-malate and its monohydrate
US2867661A (en) Non-hygroscopic antibiotic salt
US3651048A (en) Purification process
US2182075A (en) Water soluble derivatives of p-aminobenzenesulphonamide
US2208641A (en) Soluble sulphanilic acid amide derivatives
US2868804A (en) Betaine ascorbate
AT227699B (en) Process for the preparation of new quaternary 1- (2-lower. Alkyl-4-amino-5-pyrimidyl-methyl) -low. alkyl pyridinium salts
US3714166A (en) Cocarboxylase arginate and process for the production thereof
DE1693190C3 (en) Alkanes and hydroxyalkanes disubstituted by alkylsulfonyloxyethylamino groups, processes for their preparation and pharmaceutical preparations containing these compounds
US2668852A (en) Neutral calcium 4-aminosalicylate hemihydrate and preparation of the same
US2476925A (en) Preparation of therapeutic substances